Late phase II study on setting for concentraion of FK506 (tacrolimus) ointment for atopic dermatitis (No. 1).
- 1 January 1997
- journal article
- Published by Western Japan Division of JDA in The Nishinihon Journal of Dermatology
- Vol. 59 (3) , 413-426
- https://doi.org/10.2336/nishinihonhifu.59.413
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Analysis of the Cytokine Pattern Expressed In Situ in Inhalant Allergen Patch Test Reactions of Atopic Dermatitis PatientsJournal of Investigative Dermatology, 1995
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejectionThe Lancet, 1994
- Regulation of lnterleukin-5 Production by Peripheral Blood Mononuclear Cells from Atopic Patients with FK506, Cyclosporin A and GlucocorticoidInternational Archives of Allergy and Immunology, 1994
- Lesional expression of interferon-γ in atopic eczemaThe Lancet, 1994
- Atopic Dermatitis in Infants and ChildrenPediatric Clinics of North America, 1991
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1987